Current Liabilities decreased faster than Collplant Biotechnologies Ltd's Cash & cash equivalent, this led to improvement in Collplant Biotechnologies Ltd's Quick Ratio to 5, Quick Ratio remained below Collplant Biotechnologies Ltd average.

Within Medical Equipment & Supplies industry 35 other companies have achieved higher Quick Ratio than Collplant Biotechnologies Ltd in fourth quarter 2025. While Quick Ratio total ranking has improved so far during the Q4 2025 to 991, from total ranking in the third quarter 2025 at 1216.

Explain Quick Ratio?
How much Cash & cash equivalents CLGN�s has?
What are CLGN�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/CLGN/financial-strength

https://api.csimarket.com/api/v1/companies/CLGN/fundamentals

https://api.csimarket.com/api/v1/companies/CLGN/fundamentals?mode=as_of&as_of=YYYY-MM-DD

Programmatic access for models, analytics, and integration workflows.

Explore the Financial Data API

Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery

Connect Your AI Assistant

How to Connect Your AI Assistant to CSIMarket MCP MCP Server

Access this full dataset via API

Free sample Full docs All endpoints

CLGN Quick Ratio	(Dec 31 2025) Q4	0 Q3	0 Q2	0 Q1	(Dec 31 2024) Q2
Y / Y Current Liabilities Change	-21.95 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent Change	-51.06 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio MRQ	5	Subscribe	Subscribe	Subscribe	Subscribe
CLGN's Total Ranking	# 991	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities Change	-35.9 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent Change	0 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick Ratio fourth quarter 2025 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 36
Healthcare Sector	# 323
Overall Market	# 959

Quick Ratio Statistics
High	Average	Low
20.84	6.45	0.5
0		(Jun 30 2019)

Financial Statements
Collplant Biotechnologies Ltd's Current Liabilities	$ 1 Millions	Visit CLGN's Balance sheet
Collplant Biotechnologies Ltd's Cash & cash equivalent	$ 6 Millions	Visit CLGN's Balance sheet
Source of CLGN's Sales		Visit CLGN's Sales by Geography

Cumulative Collplant Biotechnologies Ltd's Quick Ratio

CLGN's Quick Ratio for the trailling 12 Months

CLGN Quick Ratio	(Dec 31 2025) 12 Months	0 12 Months	0 12 Months	0 12 Months	(Dec 31 2024) 12 Months
Y / Y Current Liabilities TTM Growth	-21.13 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent TTM Growth	-65.29 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio TTM	4.34	Subscribe	Subscribe	Subscribe	Subscribe
Total Ranking TTM	# 2654	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities TTM Growth	-4.69 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent TTM Growth	-17.36 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick ratio ranking by company, industry and sector >> Back to CLGN Financial Strength Comparisons >> Go to Compare CLGN Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in CLGN's Current Liabilities to $1.19 millions, cumulative Quick Ratio to 4.34 above the company average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 158 other companies have achieved higher Quick Ratio than Collplant Biotechnologies Ltd. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2025 from to 2654.

Explain Quick Ratio?
How much Cash & cash equivalents CLGN�s has?
What are CLGN�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 159
Healthcare Sector	# 749
Within the Market	# 2654

trailing twelve months Quick Ratio Statistics
High	Average	Low
9.55	3.54	0.98
(Dec 31 2022)		(Dec 31 2020)

Companies with similar Quick Ratio in the quarter ending Dec 31 2025, within Medical Equipment & Supplies Industry	Quick Ratio	Dec 31 2025 MRQ Cash & cash equivalent	Dec 31 2025 MRQ Current Liabilities
Envveno Medical Corporation	13.30	$ 28.212 Millions	$ 2.122 Millions
Bone Biologics Corporation	12.76	$ 5.334 Millions	$ 0.418 Millions
Talkspace Inc	10.89	$ 92.586 Millions	$ 8.501 Millions
Pulse Biosciences Inc	10.19	$ 80.735 Millions	$ 7.923 Millions
Alpha Tau Medical Ltd	10.05	$ 76.903 Millions	$ 7.652 Millions
Lemaitre Vascular Inc	9.89	$ 359.120 Millions	$ 36.323 Millions
Profound Medical Corp	9.83	$ 59.723 Millions	$ 6.075 Millions
Logicmark Inc	9.08	$ 15.368 Millions	$ 1.692 Millions
Ceribell Inc	8.86	$ 159.261 Millions	$ 17.984 Millions
Bluejay Diagnostics Inc	8.65	$ 5.165 Millions	$ 0.597 Millions
Delcath Systems Inc	8.39	$ 91.036 Millions	$ 10.849 Millions
Sight Sciences Inc	8.34	$ 91.965 Millions	$ 11.027 Millions
Carlsmed Inc	7.69	$ 109.793 Millions	$ 14.280 Millions
Rxsight Inc	7.66	$ 228.128 Millions	$ 29.774 Millions
EBR Systems, Inc.	7.57	$ 101.595 Millions	$ 13.422 Millions
Inmode Ltd	7.16	$ 555.244 Millions	$ 77.569 Millions
Beta Bionics Inc	7.09	$ 219.125 Millions	$ 30.924 Millions
Kestra Medical Technologies Ltd	6.79	$ 291.321 Millions	$ 42.931 Millions
Orchestra Biomed Holdings Inc	6.66	$ 106.512 Millions	$ 15.985 Millions
Innovative Eyewear Inc	6.23	$ 6.511 Millions	$ 1.045 Millions
Autonomix Medical Inc	6.02	$ 9.934 Millions	$ 1.650 Millions
Nutriband Inc	5.83	$ 4.575 Millions	$ 0.784 Millions
Cvrx inc	5.69	$ 75.708 Millions	$ 13.317 Millions
Aethlon Medical Inc	5.53	$ 6.956 Millions	$ 1.257 Millions
Transmedics Group Inc	5.47	$ 488.366 Millions	$ 89.305 Millions
Inspiremd Inc	5.06	$ 54.211 Millions	$ 10.712 Millions
Perspective Therapeutics Inc	5.05	$ 144.737 Millions	$ 28.679 Millions
Iradimed Corporation	5.03	$ 51.159 Millions	$ 10.180 Millions
Collplant Biotechnologies Ltd	5.00	$ 5.950 Millions	$ 1.191 Millions
Soleno Therapeutics Inc	4.98	$ 305.472 Millions	$ 61.363 Millions

Date modified: 2026-10-05T11:03:39+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.